[Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders].
The changes occurring in hemodynamics due to the effect of alpha-adreno-blocking agent pyrroxan and beta-blocking agent obzidan were studied in 20 patients with neurocirculatory dystonia and in 20 patients with stage IIB hypertensive disease. Forty healthy persons formed the control group. The results of the investigation allow for the assumption that a pharmacological test with a record of the transthoracic rheogram and the derivatives of the central pulse tracings help in the proper choice of the drug and its dosage with the state of hemodynamics and the inotropic myocardial reaction taken into account.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D002319:Cardiovascular System / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D009449:Neurocirculatory Asthenia / Q000188:drug therapy / Q000503:physiopathology; D005082:Physical Exertion; D011187:Posture
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists
Opredelenie individual'nykh izmeneniĭ reaktivnosti serdechnososudistoĭ sistemy pri naznachenii adrenergicheskikh blockatorov.